An updated review of glucocorticoid-related adverse events in patients with rheumatoid arthritis.

Mariana LuísJoão FreitasFlávio CostaFrank ButtgereitMaarten BoersDa Silva JapTânia Santiago

Published in: Expert opinion on drug safety (2019)

In the meantime, adherence to recommendations and consensus on standardized methodologies for monitoring and reporting adverse events is essential to improve our knowledge and competence in the best management of glucocorticoids.

Keyphrases

clinical practice
healthcare
adverse drug
type diabetes
emergency department
glycemic control
adipose tissue